Evaluation of ALT-2074 in Subjects With Type-2 Diabetes, Haptoglobin Type 2-2 Genotype and Coronary Artery Disease
This study has been completed.
Sponsor:
Synvista Therapeutics, Inc
Information provided by:
Synvista Therapeutics, Inc
ClinicalTrials.gov Identifier:
NCT00491543
First received: June 23, 2007
Last updated: July 1, 2008
Last verified: June 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2008 |
| Estimated Primary Completion Date: | No date given |